Observational studyClinical oral investigations2025
Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center.
Observational study in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A scientometric study on research trends and characteristics of medication-related osteonecrosis of the jaw.Journal of dental sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of this study was to evaluate the clinicoradiological features and treatment approaches of MRONJ in cancer patients rehabilitated with osseointegrated implants. MATERIALS AND
methodsMedical records of 147 patients who developed MRONJ over a 16-year period were evaluated. Demographic data, type of antiresorptive medication (AR) used, route of administration, frequency, and time of use were collected. Staging, clinical and imaging characteristics, and treatment for MRONJ were also collected.
resultsA total of 25 patients (17%) presented with implants in the region affected by MRONJ, of whom 23 (92%) underwent implant placement prior to the initiation of AR. The total number of affected implants was 42 and most had an external hexagon connection (n = 25, 59.5%). Among these patients, 28 MRONJ areas were identified, most of which were classified as stage 2 (n = 17, 60.7%) and located in the posterior mandible (n = 16, 57.1%). Pain (n = 17, 68%) and the presence of osteolytic areas (n = 21, 84%) were the most commonly observed clinical and imaging characteristics. Surgical treatment was the preferred approach in 84% (n = 21) of cases.
conclusionsMRONJ involving implants occurred mainly in patients rehabilitated before AR, with frequent involvement of the posterior mandible, pain, and osteolytic areas on radiological imaging. Surgical intervention showed a high rate of clinical success. CLINICAL RELEVANCE: Implants placed prior to AR may act as local risk factors for MRONJ in cancer patients, underscoring the need for careful evaluation of existing implants before starting treatment.
Indexed as
Identifiers
40892316What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.